Filter
833
Text search:
pharmaceutical
manufacturers
Featured
Recommendations
84
New Publications
196
Language
Document type
No document type
369
Studies & Reports
183
Guidelines
149
Manuals
59
Strategic & Response Plan
41
Fact sheets
13
Training Material
8
Situation Updates
7
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
Global
40
India
28
Kenya
27
Nigeria
22
Western and Central Europe
22
Ethiopia
20
South Africa
15
Uganda
11
Ukraine
11
Sierra Leone
10
Eastern Europe
10
Philippines
9
Tanzania
9
Rwanda
9
Ghana
8
Zimbabwe
8
Malawi
8
Namibia
8
Latin America and the Carribbean
8
Nepal
7
Liberia
6
Bangladesh
6
Eastern Europe and Central Asia
6
Africa
6
Zambia
5
Indonesia
5
Myanmar / Burma
5
South–East Asia Region
5
Senegal
4
Syria
4
Cambodia
4
Thailand
4
Botswana
4
West and Central Africa
4
Burkina Faso
3
Haiti
3
East and Southern Africa
3
Asia
3
Egypt
2
Sudan
2
Eswatini/ Swaziland
2
North Macedonia
2
Serbia
2
Middle East and North Africa
2
Western Pacific Region
2
Albania
2
Laos
2
Russia
2
Kyrgyzstan
2
North America
2
Jamaica
2
Congo, Democratic Republic of
1
Mali
1
USA
1
Cameroon
1
Somalia
1
Pakistan
1
South Sudan
1
Afghanistan
1
Germany
1
China
1
Mozambique
1
Papua New Guinea
1
Benin
1
Lesotho
1
Chile
1
Armenia
1
Mongolia
1
Timor Leste/ East Timor
1
Tajikistan
1
Bulgaria
1
Moldova
1
Iran
1
Uzbekistan
1
Australia
1
Kazakhstan
1
Georgia
1
Vietnam
1
Gabon
1
Turkmenistan
1
Denmark
1
Maldives
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
260
Clinical Guidelines
90
Public Health
45
Pharmacy & Technologies
35
Key Resources
31
Women & Child Health
28
Capacity Building
7
Toolboxes
Pharmacy
114
AMR
104
COVID-19
61
TB
46
HIV
43
Rapid Response
42
Mental Health
33
Global Health Education
18
Planetary Health
18
NTDs
18
NCDs
18
Conflict
15
Caregiver
12
Health Financing Toolbox
10
Specific Hazards
7
Disability
6
Ebola
5
Polio
5
Refugee
5
Zika
2
Cholera
1
Natural Hazards
1
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys
...
The document "Chronic Respiratory Diseases: A Handbook for Pharmacists" outlines the significant role pharmacists play in managing asthma and COPD, emphasizing patient education, disease prevention, medication management, and promoting healthy lifestyles. It highlights the importance of pharmacists
...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight
...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
Survey of the Quality of Selected Antimalarial Medicines Circulating in Six Countries of Sub-Saharan Africa
recommended
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o
...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
The Antimicrobial Resistance Benchmark has evaluated for the second time how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics. Although we can see progress — it’s hanging by a thread.
We have reac
...
Drug Advisory Board
This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the ep
...
Revision Bulletin ESPNF
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which the pharmaceutical industry was restricting access to Covi
...
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the pop
...
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedu
...
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
This guidance should be followed if an unlicensed medicine is prepared in
a registered pharmacy. The preparation of an unlicensed medicine (for
example unlicensed methadone, or menthol in aqueous cream) in a pharmacy is called ‘extemporaneous preparation’.
The guidance should be read alon
...
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been
...
Prices people pay for medicines.
